Accord UK Pharmaceutical Import Profile — United Kingdom (DGFT 2022–2026)

Name: Accord UK Pharmaceutical Import Records from India — 11 Products, $7.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Accord UK — Pharmaceutical Importer Profile (2026) | 11 Products, $7.7M Trade | TransData Nexus

Accord UK

Pharmaceutical Importer · United Kingdom · Advanced Oncology Focus · $7.7M Total Trade · DGFT Verified

Accord UK is a pharmaceutical importer based in United Kingdom with a total trade value of $7.7M across 11 products in 5 therapeutic categories. Based on 331 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Accord UK sources from 2 verified Indian suppliers, with Intas Pharmaceuticals Limited accounting for 98.4% of imports.

Accord UK — Import Portfolio & Supplier Network

Accord UK import network — 11 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Accord UK?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Intas Pharmaceuticals Limited	$22.6M	1,567	98.4%
Apex Laboratories Private Limited	$363.9K	8	1.6%

Accord UK sources from 2 verified Indian suppliers across .

What Formulations Does Accord UK Import?

Formulation	Value	Ships
Pharma drugs & medi progesterone 100MG 3x10c(accord-uk as per	$390.6K	14
Pharma drugs & medi apixaban 5MG 4x14t(accord-uk as per	$368.3K	17
Pharma drugs & medi letrozole 2.5MG	$362.6K	15
Pharma drugs & medi montelukast 10MG	$353.6K	9
Pharma drugs & medi finasteride 1MG	$289.7K	19
Pharma drugs & medi mycophenol mmf 500MG 5x10t(accord-uk as per	$250.4K	9
Pharma drugs & medi pelgraz 6MG/0.6ML	$250.0K	5
Pharma drugs & medi montelukast 10MG 2x14t(accord-uk as per	$215.6K	10
Pharma drugs & medi pregabalin 75MG	$200.2K	5
Pharma drugs & medi levetiracetam 1000MG	$198.1K	8
Pharma drugs & medi tolterodine	$178.4K	13
Pharma drugs & medi eplerenone 25MG	$170.9K	4
Pharma drugs & medi lercanidipine hcl 10MG 2x14t(accord-uk as per	$170.1K	9
Pharma drugs & medi donepezil 10MG 2x14t g1(accord-uk as per	$156.6K	27
Pharma drugs & medi pregabalin 300MG	$154.9K	7

Accord UK imports 677 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 11 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Apixaban	Cardiovascular	$1.9M	57	1.1%	14
2	Letrozole	Advanced Oncology	$1.4M	49	4.5%	3
3	Montelukast	Respiratory	$1.3M	45	0.8%	14
4	Irinotecan	Oncology	$1.1M	40	2.6%	9
5	Pioglitazone	Diabetes & Endocrine	$452.6K	61	1.2%	17
6	Cytarabine	Advanced Oncology	$441.7K	25	4.1%	3
7	Exemestane	Advanced Oncology	$281.6K	7	1.9%	13
8	Anastrozole	Advanced Oncology	$246.6K	20	0.2%	18
9	Etoposide	Oncology	$235.3K	15	2.2%	10
10	Fludarabine	Advanced Oncology	$189.4K	5	6.6%	3
11	Busulfan	Advanced Oncology	$111.6K	7	2.3%	10

Accord UK imports 11 pharmaceutical products across 5 categories into United Kingdom totaling $7.7M.

Accord UK — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Accord UK is a prominent pharmaceutical company specializing in the importation and distribution of finished pharmaceutical formulations within the United Kingdom. Established in 1903, the company has a longstanding presence in the UK's pharmaceutical sector. Headquartered in Barnstaple, Devon, Accord UK operates as a private limited company, with its registered office located at Whiddon Valley, Barnstaple, EX32 8NS. (find-and-update.company-information.service.gov.uk)

As a subsidiary of the Intas Pharmaceuticals group, Accord UK plays a pivotal role in the UK's pharmaceutical supply chain. The company is vertically integrated, overseeing all stages of pharmaceutical development and production. This integration enables Accord UK to deliver high-quality medicines to patients more efficiently and economically. With six EU GMP-approved manufacturing plants and a packing site near Cambridge, Accord UK boasts some of the largest production capacities in the world.

2Distribution Network

Accord UK's distribution network is strategically designed to ensure the efficient delivery of pharmaceutical products across the United Kingdom. The company's primary warehouse is situated at Whiddon Valley, Barnstaple, EX32 8NS, serving as the central hub for its logistics operations. This location facilitates streamlined distribution to various regions within the UK. Additionally, Accord UK maintains a packing site near Cambridge, enhancing its logistical capabilities and ensuring timely delivery of products to healthcare providers and pharmacies nationwide.

3Industry Role

In the United Kingdom's pharmaceutical supply chain, Accord UK functions as a key importer and distributor of finished pharmaceutical formulations. The company sources a diverse range of pharmaceutical products from international suppliers, including India, and ensures their compliance with UK regulatory standards. Accord UK's role is critical in bridging the gap between global pharmaceutical manufacturers and the UK's healthcare system, facilitating the availability of essential medicines to patients across the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Accord UK

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Accord UK's sourcing strategy exhibits a significant concentration on a limited number of suppliers, particularly from India. The company's total import value from India amounts to $7.7 million USD, encompassing 331 shipments across 11 products from two primary suppliers:

INTAS PHARMACEUTICALS LIMITED: $22.6 million USD (98.4% of shipments)
APEX LABORATORIES PRIVATE LIMITED: $364,000 USD (1.6% of shipments)

This heavy reliance on a single supplier, INTAS PHARMACEUTICALS LIMITED, could pose risks related to supply chain disruptions, pricing fluctuations, and potential regulatory changes in the supplier's country. However, the substantial volume of imports from INTAS suggests a strategic partnership, likely characterized by favorable terms and a history of reliable supply. The limited number of suppliers may also indicate a focused procurement strategy aimed at maintaining product quality and consistency.

2Supply Chain Resilience

Accord UK's supply chain resilience is influenced by its concentrated sourcing from a few suppliers, particularly INTAS PHARMACEUTICALS LIMITED. While this concentration can lead to cost efficiencies and streamlined operations, it also exposes the company to potential risks such as supply disruptions, geopolitical issues, and regulatory changes affecting the supplier's operations. The limited number of suppliers may also indicate a focused procurement strategy aimed at maintaining product quality and consistency. To enhance resilience, Accord UK could consider diversifying its supplier base and establishing contingency plans to mitigate potential disruptions.

Importing Pharmaceuticals into United Kingdom — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Kingdom

1Regulatory Authority & Framework

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) serves as the primary regulatory authority overseeing the safety, efficacy, and quality of medicinal products. The MHRA operates under the Human Medicines Regulations 2012 (SI 2012/1916), which transposes EU directives into UK law. This framework governs various aspects of pharmaceutical imports, including marketing authorization, manufacturing, and distribution. For Indian pharmaceutical exporters, obtaining a UK Marketing Authorization (MA) is essential for placing products on the UK market. The MHRA evaluates applications for MAs, ensuring that imported medicines meet the required standards for safety, quality, and efficacy. (cms.mhra.gov.uk)

2Import Licensing & GMP

Import licensing in the UK is regulated by the MHRA, which requires importers to hold a valid Manufacturer's Authorization (MIA) for the importation and distribution of medicinal products. Accord UK holds MIA number UK MIA 142, authorizing it to import and distribute human medicinal products. Additionally, the MHRA mandates that imported pharmaceutical products comply with Good Manufacturing Practice (GMP) standards. The UK recognizes GMP certifications from various regulatory bodies, including the European Union (EU), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). For Indian exporters, ensuring that their manufacturing facilities are certified by these recognized bodies is crucial for facilitating the importation of their products into the UK market. (cms.mhra.gov.uk)

Accord UK — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Accord UK's product strategy focuses on importing a diverse range of pharmaceutical formulations across multiple therapeutic categories, including oncology, cardiovascular, and diabetes treatments. This approach aligns with the company's mission to provide essential medicines to the UK market, addressing critical healthcare needs. The substantial import values in these categories indicate a strong market demand and Accord UK's commitment to meeting the therapeutic requirements of the UK population.

2Sourcing Profile

Accord UK's sourcing strategy emphasizes the importation of generic and biosimilar medicines, primarily from India. The company's procurement focuses on finished pharmaceutical formulations, ensuring compliance with UK regulatory standards. India's robust pharmaceutical manufacturing sector, characterized by its adherence to international GMP standards, makes it a strategic partner for Accord UK in fulfilling its sourcing needs.

3Market Positioning

Accord UK's product mix positions the company as a significant supplier to both retail pharmacies and hospital groups within the United Kingdom. By offering a broad portfolio of generic and biosimilar medicines across various therapeutic areas, Accord UK caters to the diverse needs of the healthcare sector, ensuring the availability of affordable and high-quality pharmaceutical products to patients nationwide.

Seller's Guide — How to Become a Supplier to Accord UK

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the UK market by aligning with Accord UK's sourcing strategy. By ensuring compliance with UK regulatory standards and obtaining the necessary certifications, Indian exporters can position themselves as potential suppliers to Accord UK. Identifying gaps in Accord UK's current sourcing, such as unmet therapeutic needs or product shortages, can provide avenues for new suppliers to establish partnerships and expand their market presence in the UK.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to Accord UK and the broader UK market must ensure that their manufacturing facilities are certified by recognized bodies such as the EU, WHO, or PIC/S. Obtaining a UK Marketing Authorization (MA) from the MHRA is essential for placing products on the UK market. Additionally

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Accord UK

What products does Accord UK import from India?

Accord UK imports 11 pharmaceutical products across 5 categories. Top imports: Apixaban ($1.9M), Letrozole ($1.4M), Montelukast ($1.3M), Irinotecan ($1.1M), Pioglitazone ($452.6K).

Who supplies pharmaceuticals to Accord UK from India?

Accord UK sources from 2 verified Indian suppliers. The primary supplier is Intas Pharmaceuticals Limited (98.4% of imports, $22.6M).

What is Accord UK's total pharmaceutical import value?

Accord UK's total pharmaceutical import value from India is $7.7M, based on 331 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Accord UK focus on?

Accord UK imports across 5 categories. The largest: Advanced Oncology (35.5%), Cardiovascular (24.7%), Oncology (17.1%).

Get Full Accord UK Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.